TAIM
VRTX icon

Te Ahumairangi Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Te Ahumairangi Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Hold
5,135
– – 0.38% 78
2025
Q4 		$2.33M Sell
5,135
-590
-10% -$254K 0.42% 76
2025
Q3 		$2.24M Sell
5,725
-260
-4% -$109K 0.38% 77
2025
Q2 		$2.67M Sell
5,985
-3,133
-34% -$1.44M 0.48% 67
2025
Q1 		$4.42M Sell
9,118
-3,295
-27% -$1.54M 0.94% 40
2024
Q4 		$5M Sell
12,413
-926
-7% -$429K 1.04% 32
2024
Q3 		$6.17M Sell
13,339
-550
-4% -$264K 1.09% 33
2024
Q2 		$6.51M Sell
13,889
-845
-6% -$367K 1.25% 28
2024
Q1 		$6.16M Buy
14,734
+470
+3% +$199K 1.07% 35
2023
Q4 		$5.8M Sell
14,264
-4,105
-22% -$1.52M 1.1% 35
2023
Q3 		$6.39M Sell
18,369
-3,925
-18% -$1.37M 1.04% 36
2023
Q2 		$7.84M Buy
22,294
+425
+2% +$143K 1.07% 36
2023
Q1 		$6.89M Hold
21,869
– – 0.99% 38
2022
Q4 		$6.32M Buy
21,869
+5,894
+37% +$1.8M 0.99% 40
2022
Q3 		$4.63M Buy
15,975
+35
+0.2% +$10.1K 0.78% 54
2022
Q2 		$4.49M Buy
15,940
+1,160
+8% +$310K 0.68% 60
2022
Q1 		$3.86M Buy
14,780
+1,010
+7% +$240K 0.52% 69
2021
Q4 		$3.02M Buy
+13,770
New +$2.68M 0.39% 74

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Te Ahumairangi Investment Management's VRTX Position: Q1 2026 in Review

Te Ahumairangi Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 5,135 shares worth $2.29M. The position accounts for 0.38% of the portfolio, ranked #78.

Te Ahumairangi Investment Management first reported a position in VRTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.84M in Q2 2023. 1,692 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Te Ahumairangi Investment Management held 5,135 shares of Vertex Pharmaceuticals worth $2.29M as of Q1 2026.
  • Te Ahumairangi Investment Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.38% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #78 holding.
  • Te Ahumairangi Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Te Ahumairangi Investment Management's Vertex Pharmaceuticals position peaked at $7.84M in Q2 2023.
  • 1,692 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.